FDA clears Fiber Imaging Technologies' flexible endoscope:
This article was originally published in Clinica
Fiber Imaging Technologies (FIT) and its German partner Schoelly Fiberoptic have received US FDA 510(k) clearance for their flexible, steerable endoscope for use during larynx and pharynx diagnostic examinations. The naso-laryngo-pharyngoscope has a working length of 300mm, a deflection range of 150 degrees up or down, a 25mm flexible tip section and a wide-angled field of view. It provides a sharp image, panoramic or detailed examination and one-handed operation during diagnostic procedures, said Worcester, Massachusetts-based FIT, a subsidiary of Luxtec, also based in Worcester.
You may also be interested in...
ConMed Corp. is company of two halves ̶ general surgery and orthopedics – and is readying itself for a renewed assault on these two markets on the back of a technology pipeline, targeted acquisitions and a new growth-winning culture, says CFO Todd Garner.
Drug pricing and access issues expose the pharmaceutical sector especially acutely to calls for companies to meet ethical and social goals, alongside commercial ones. Digital is up-ending pharma’s processes, its workplaces and its consumers. R&D productivity is spluttering. Amid this turmoil, CEOs highlight company culture – the way an organization behaves – as a crucial ingredient for success. But what is a “right” culture? Organizational culture is neither static nor singular. It is continuously influenced by acquisitions, markets, new technologies and new generations. And pharma’s history suggests that culture change cannot happen without sufficient people change.